Long intergenic non-protein coding RNA 115 (LINC00115) aggravates retinoblastoma progression by targeting microRNA miR-489-3p that downregulates 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (PFKFB2)

References

• AlAli A, Kletke S, Gallie B, et al. Retinoblastoma for pediatric ophthalmologists. Asia Pac J Ophthalmol (Phila). 2018;7(3):160–168.
   PubMed Web of Science ®Google Scholar
• Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, et al. [Retinoblastoma update]. Arch Pediatr. 2016;23(1):112–116.
   PubMed Web of Science ®Google Scholar
• Rao R, Honavar SG. Retinoblastoma. Indian J Pediatr. 2017;84(12):937–944.
   PubMed Web of Science ®Google Scholar
• Fabian ID, Onadim Z, Karaa E, et al. The management of retinoblastoma. Oncogene. 2018;37(12):1551–1560.
   PubMed Web of Science ®Google Scholar
• Goodrich DW, Lee WH. The molecular genetics of retinoblastoma. Cancer Surv. 1990;9(3):529–554.
   PubMedGoogle Scholar
• Berry JL, Polski A, and Cavenee WK, et al. The RB1 story: characterization and cloning of the first tumor suppressor gene. Genes (Basel). 2019;10(11):879.
   PubMed Web of Science ®Google Scholar
• Lohmann D, Horsthemke B. [Genetic and molecular diagnostics in retinoblastoma]. Klin Monbl Augenheilkd. 1998;213(4):191–196.
   PubMed Web of Science ®Google Scholar
• Singh L, Kashyap S. Update on pathology of retinoblastoma. Int J Ophthalmol. 2018;11(12):2011–2016.
   PubMed Web of Science ®Google Scholar
• Heng L, Jia Z, Sun J, et al. Integrated analysis of competing endogenous RNAs network reveals potential signatures in osteosarcoma development. Technol Cancer Res Treat. 2020;19:1533033820957025.
   Web of Science ®Google Scholar
• Lyu X, Ma Y, Wu F, et al. LncRNA NKILA inhibits retinoblastoma by downregulating lncRNA XIST. Curr Eye Res. 2019;44(9):975–979.
   PubMed Web of Science ®Google Scholar
• Ni H, Chai P, Yu J, et al. LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter. Cell Death Dis. 2020;11(5):306.
   PubMed Web of Science ®Google Scholar
• Wu XZ, Cui HP, Lv HJ, et al. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p. Biomed Pharmacother. 2019;112:108627.
   PubMed Web of Science ®Google Scholar
• Feng W, Li B, Wang J, et al. Long non-coding RNA LINC00115 contributes to the progression of colorectal cancer by targeting miR-489-3p via the PI3K/AKT/mTOR pathway. Front Genet. 2020;11:567630.
   PubMed Web of Science ®Google Scholar
• Yuan C, Luo X, Duan S, et al. Long noncoding RNA LINC00115 promotes breast cancer metastasis by inhibiting miR-7. FEBS Open Bio. 2020;10(7):1230–1237.
   PubMed Web of Science ®Google Scholar
• Tang J, Yu B, Li Y, et al. TGF-β-activated lncRNA LINC00115 is a critical regulator of glioma stem-like cell tumorigenicity. EMBO Rep. 2019;20(12):e48170.
   PubMed Web of Science ®Google Scholar
• Jiang B, Hailong S, Yuan J, et al. Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis. Biomed Pharmacother. 2018;108:500–507.
   PubMed Web of Science ®Google Scholar
• Ooi S, Liao Y, Liu P, et al. Identification of long noncoding RNA expression profiles in HPV-negative cervical cancer. Gynecol Obstet Invest. 2020;85(5):377–387.
   PubMed Web of Science ®Google Scholar
• Li DS, Ainiwaer JL, Sheyhiding I, et al. Identification of key long non-coding RNAs as competing endogenous RNAs for miRNA-mRNA in lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 2016;20(11):2285–2295.
   PubMed Web of Science ®Google Scholar
• Jin LP, Liu T, Meng FQ, et al. Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma. BMC Cancer. 2020;20(1):968.
   PubMed Web of Science ®Google Scholar
• Huang Y, Shen XJ, Zou Q, et al. Biological functions of microRNAs: a review. J Physiol Biochem. 2011;67(1):129–139.
   PubMed Web of Science ®Google Scholar
• Xu HK, Wang XD, Wang DG, et al. miR-340 exerts suppressive effect on retinoblastoma progression by targeting KIF14. Curr Eye Res. 2021;46(2):232–238.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhao M, Li L, et al. miR-491-3p is downregulated in retinoblastoma and inhibit tumor cells growth and metastasis by targeting SNN. Biochem Genet. 2021;59(2):453–474.
   PubMed Web of Science ®Google Scholar
• Sun D, Li T, Xin H, et al. miR-489-3p inhibits proliferation and migration of bladder cancer cells through downregulation of histone deacetylase 2. Oncol Lett. 2020;20(4):8.
   PubMed Web of Science ®Google Scholar
• Zheng B, Chen T. MiR-489-3p inhibits cell proliferation, migration, and invasion, and induces apoptosis, by targeting the BDNF-mediated PI3K/AKT pathway in glioblastoma. Open Life Sci. 2020;15(1):274–283.
   PubMed Web of Science ®Google Scholar
• Chen L, Chen L, Qin Z, et al. Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2. Acta Pharm Sin B. 2019;9(5):1008–1020.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhu X, Yan Z, et al. miR-489-3p/SIX1 axis regulates melanoma proliferation and glycolytic potential. Mol Ther Oncolytics. 2020;16:30–40.
   PubMed Web of Science ®Google Scholar
• Wojnar J, Kalina Z. [Ultrasonographic studies in evaluating the degree of advancement of stomach cancer]. Polski tygodnik lekarski (Warsaw, Poland: 1960). 1987;42(27–28):849–852.
   PubMedGoogle Scholar
• Ozcan SC, Sarioglu A, Altunok TH, et al. PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells. Mol Cell Biochem. 2020;470(1–2):115–129.
   PubMed Web of Science ®Google Scholar
• Ji D, Lu ZT, Li YQ, et al. MACC1 expression correlates with PFKFB2 and survival in hepatocellular carcinoma. Asian Pac J Cancer Prev. 2014;15(2):999–1003.
   PubMedGoogle Scholar
• Liu H, Chen K, Wang L, et al. miR-613 inhibits Warburg effect in gastric cancer by targeting PFKFB2. Biochem Biophys Res Commun. 2019;515(1):37–43.
   PubMed Web of Science ®Google Scholar
• Ortiz MV, Dunkel IJ. Retinoblastoma. J Child Neurol. 2016;31(2):227–236.
   PubMed Web of Science ®Google Scholar
• Yin D, Lu X. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells. Bioengineered. 2021;12(1):225–239.
   PubMed Web of Science ®Google Scholar
• Liu K, Zhao D, Wang D. LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2020;11(1):11–18.
   PubMed Web of Science ®Google Scholar
• Chen L, Shi J, Wu Y, et al. CircRNA CDR1as promotes hepatoblastoma proliferation and stemness by acting as a miR-7-5p sponge to upregulate KLF4 expression. Aging (Albany NY). 2020;12(19):19233–19253.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Li YQ, Lu JH, Bao XM, et al. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1. J Exp Clin Cancer Res. 2015;34:130.
   PubMed Web of Science ®Google Scholar
• Hamano R, Miyata H, Yamasaki M, et al. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res. 2011;17(9):3029–3038.
   PubMed Web of Science ®Google Scholar
• Li X, Liu F, Lin B, et al. miR‑150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma. Int J Oncol. 2017;50(4):1097–1108.
   PubMed Web of Science ®Google Scholar
• Bai, P , Li, W , Wan, Z et al . miR-489-3p inhibits prostate cancer progression by targeting DLX1 [Retraction]. Cancer Manag Res. 2020;12:12581.
   PubMed Web of Science ®Google Scholar
• Bai P, Li W, Wan Z, et al. miR-489-3p inhibits prostate cancer progression by targeting DLX1. Cancer Manag Res. 2020;12:2719–2729.
   PubMed Web of Science ®Google Scholar
• Ying X, Zhang W, Fang M, et al. LncRNA SNHG5 regulates SOX4 expression through competitive binding to miR-489-3p in acute myeloid leukemia. Inflamm Res. 2020;69(6):607–618.
   PubMed Web of Science ®Google Scholar
• Li C, Gao Q, Wang M, et al. LncRNA SNHG1 contributes to the regulation of acute myeloid leukemia cell growth by modulating miR-489-3p/SOX12/Wnt/β-catenin signaling. J Cell Physiol. 2021;236(1):653–663.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Wang G, Zhu W, et al. LEF1-AS1 accelerates tumorigenesis in glioma by sponging miR-489-3p to enhance HIGD1A. Cell Death Dis. 2020;11(8):690.
   PubMed Web of Science ®Google Scholar
• Fu D, Zhang Y, Cui H. Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas. Am J Cancer Res. 2018;8(2):245–255.
   PubMed Web of Science ®Google Scholar
• Pan X, Li H, Tan J, et al. miR-1297 suppresses osteosarcoma proliferation and aerobic glycolysis by regulating PFKFB2. Onco Targets Ther. 2020;13:11265–11275.
   PubMed Web of Science ®Google Scholar
• Yang H, Shu Z, Jiang Y, et al. 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-2 regulates TP53-dependent paclitaxel sensitivity in ovarian and breast cancers. Clin Cancer Res. 2019;25(18):5702–5716.
   PubMed Web of Science ®Google Scholar
• Qu J, Yang J, Chen M, et al. CircFLNA acts as a sponge of miR-646 to facilitate the proliferation, metastasis, glycolysis, and apoptosis inhibition of gastric cancer by targeting PFKFB2. Cancer Manag Res. 2020;12:8093–8103.
   PubMed Web of Science ®Google Scholar
• Zhao SJ, Shen YF, Li Q, et al. SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway. Cell Death Dis. 2018;9(3):390.
   PubMedGoogle Scholar
• Wang L, Cho KB, and Li Y, et al. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 2019;20(22):5758.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang Z, Gao M, et al. lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p. Open Med (Wars). 2021;16(1):931–943.
   PubMedGoogle Scholar
• Wang X, Su Y, Yin C. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-no-lysine kinases 1 (WNK1) axis. Bioengineered. 2021;12(2):11622–11633.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Wang L. LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p. Cell Cycle. 2020;19(3):290–299.
   PubMed Web of Science ®Google Scholar